CA1339075C - Methodes et compositions pour l'administration dose-effet non invasive de medicaments lipophiles - Google Patents

Methodes et compositions pour l'administration dose-effet non invasive de medicaments lipophiles

Info

Publication number
CA1339075C
CA1339075C CA000610329A CA610329A CA1339075C CA 1339075 C CA1339075 C CA 1339075C CA 000610329 A CA000610329 A CA 000610329A CA 610329 A CA610329 A CA 610329A CA 1339075 C CA1339075 C CA 1339075C
Authority
CA
Canada
Prior art keywords
drug
patient
lollipop
dose
insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000610329A
Other languages
English (en)
Inventor
Theodore H. Stanley
Brian Hague
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Utah Research Foundation UURF
Original Assignee
University of Utah Research Foundation UURF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Utah Research Foundation UURF filed Critical University of Utah Research Foundation UURF
Priority to CA000610329A priority Critical patent/CA1339075C/fr
Application granted granted Critical
Publication of CA1339075C publication Critical patent/CA1339075C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000610329A 1989-09-05 1989-09-05 Methodes et compositions pour l'administration dose-effet non invasive de medicaments lipophiles Expired - Lifetime CA1339075C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000610329A CA1339075C (fr) 1989-09-05 1989-09-05 Methodes et compositions pour l'administration dose-effet non invasive de medicaments lipophiles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000610329A CA1339075C (fr) 1989-09-05 1989-09-05 Methodes et compositions pour l'administration dose-effet non invasive de medicaments lipophiles

Publications (1)

Publication Number Publication Date
CA1339075C true CA1339075C (fr) 1997-07-29

Family

ID=4140557

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000610329A Expired - Lifetime CA1339075C (fr) 1989-09-05 1989-09-05 Methodes et compositions pour l'administration dose-effet non invasive de medicaments lipophiles

Country Status (1)

Country Link
CA (1) CA1339075C (fr)

Similar Documents

Publication Publication Date Title
US4671953A (en) Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics
US5484602A (en) Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities
US5132114A (en) Compositions and methods of manufacture of compressed powder medicaments
US4863737A (en) Compositions and methods of manufacture of compressed powder medicaments
JP2717024B2 (ja) 口腔溶解性薬剤組成物及びその製造方法
US6358060B2 (en) Two-stage transmucosal medicine delivery system for symptom relief
US6197334B1 (en) Lozenge and method of making
US6103257A (en) System for delivering pharmaceuticals to the buccal mucosa
AU645966B2 (en) Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
CA1339075C (fr) Methodes et compositions pour l'administration dose-effet non invasive de medicaments lipophiles
AU684888B2 (en) Method and compositions for noninvasive dose to effect administration of lipophilic drugs
JP2801050B2 (ja) 圧縮粉末薬剤
CA1339080C (fr) Methodes et compositions pour l'administration dose-effet non invasive de medicaments agissant au niveau cardiovascular ou renovasculaire
CA1339190C (fr) Compositions et methodes de fabrication de medicaments dans des poudres comprimees

Legal Events

Date Code Title Description
MKEX Expiry

Effective date: 20140729